Novo Nordisk A/S
NVO
$78.11
-$0.84-1.06%
Weiss Ratings | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Weak | |||
Risk Grade | D+ | |||
Reward Grade | B | |||
Rating Factors | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Good | |||
Growth Index | Excellent | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.03 | |||
Price History | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -13.83% | |||
30-Day Total Return | -10.74% | |||
60-Day Total Return | -28.46% | |||
90-Day Total Return | -30.48% | |||
Year to Date Total Return | -10.75% | |||
1-Year Total Return | -40.02% | |||
2-Year Total Return | 13.04% | |||
3-Year Total Return | 58.54% | |||
5-Year Total Return | 185.53% | |||
52-Week High % Change | -46.71% | |||
52-Week Low % Change | 1.45% | |||
Price | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $148.15 | |||
52-Week Low Price | $77.82 | |||
52-Week Low Price (Date) | Feb 14, 2025 | |||
52-Week High Price (Date) | Jun 25, 2024 | |||
Valuation | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 354.66B | |||
Enterprise Value | 365.79B | |||
Price/Earnings (TTM) | 24.05 | |||
Earnings Per Share (TTM) | 3.28 | |||
Earnings Per Share Growth | 21.47% | |||
Price/Earnings To Growth | 1.12 | |||
Price/Sales (TTM) | 8.36 | |||
Price/Book (Q) | 17.60 | |||
Enterprise Value/Revenue (TTM) | 8.69 | |||
Price | $78.11 | |||
Enterprise Value/EBITDA (TTM) | 16.85 | |||
Enterprise Value/EBIT | 18.05 | |||
Market Cap Category | Mega Cap | |||
Dividends and Shares | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 4.46B | |||
Dividend Yield | 1.30% | |||
Div. Per Share (Most Recent) | $0.36 | |||
Dividend Per Share (TTM) | $1.03 | |||
Payout Ratio (TTM) | 44.06% | |||
Dividend Per Share (Most Recent) | $0.36 | |||
Company Info | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 45 44 44 88 88 | |||
Address | -- | |||
Website | www.novonordisk.com | |||
Country | Denmark | |||
Year Founded | 1923 | |||
Profitability | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 48.16% | |||
Profit Margin | 34.80% | |||
Management Effectiveness | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 22.77% | |||
Return on Equity | 82.02% | |||
Income Statement | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 42.09B | |||
Total Revenue (TTM) | 42.09B | |||
Revenue Per Share | $9.45 | |||
Gross Profit (TTM) | 35.77B | |||
EBITDA (TTM) | 21.71B | |||
EBIT (TTM) | 20.27B | |||
Net Income (TTM) | 14.65B | |||
Net Income Avl. to Common (TTM) | 14.65B | |||
Total Revenue Growth (Q YOY) | 28.79% | |||
Earnings Growth (Q YOY) | 27.24% | |||
EPS Diluted (TTM) | 3.28 | |||
EPS Diluted Growth (Q YOY) | 27.85% | |||
Balance Sheet | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 3.65B | |||
Cash Per Share (Q) | $0.82 | |||
Total Current Assets (Q) | 22.34B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 19.92B | |||
Current Ratio (Q) | 0.740 | |||
Book Value Per Share (Q) | $4.49 | |||
Total Assets (Q) | 64.66B | |||
Total Current Liabilities (Q) | 30.20B | |||
Total Debt (Q) | 14.27B | |||
Total Liabilities (Q) | 44.74B | |||
Total Common Equity (Q) | 19.92B | |||
Cash Flow | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -18.53B | |||
Cash from Financing (TTM) | 1.12B | |||
Net Change in Cash (TTM) | 241.41M | |||
Levered Free Cash Flow (TTM) | 9.07B | |||
Cash from Operations (TTM) | 17.59B | |||